Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Learn how US total market index funds can simplify retirement investing by providing broad exposure, low costs, and diversified growth opportunities.
28,342 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Geopolitical tensions push crypto into a primary-market role, according to Bitwise, as onchain finance gains speed am...
As March unfolds, the stock market today, march narrative centers on margins, capex trends, and AI-driven demand. Thi...
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Bitwise’s Matt Hougan argues that Strategy’s role as Bitcoin’s dominant corporate buyer is shifting as institutions s...
Bitcoin closed June at a two-year low as ETF outflows accelerated and institutional interest remained restrained. The...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
A sudden, sizable stake in Resideo Technologies has sent its stock climbing 66%. Alta Fox Capital Management disclose...
A major institutional stake in TTMI has sparked fresh debates about the stock's risk and reward. This guide breaks do...
A high-profile lawsuit raises questions about payout rules and regulatory oversight in prediction markets. This artic...
A single company dominates a crucial industry, changing the odds for investors. This piece breaks down what taiwan se...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...